Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ADAMIS PHARMACEUTICALS CORPORATION

(ADMP)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Adamis Pharmaceuticals Solicits Proxies from Shareholders

07/01/2021 | 08:00am EDT

On July 1, 2021, Adamis Pharmaceuticals Corporation announced that it has issued letter to stockholders and urged them to vote for the 5 Company nominees and reject the nominees of Jerald Hammann.


ę S&P Capital IQ 2021
All news about ADAMIS PHARMACEUTICALS CORPORATION
09/20NORTH AMERICAN MORNING BRIEFING : Stock Futures -3-
DJ
09/20ADAMIS PHARMACEUTICALS CORPORATION(N : ADMP) added to S&P Global BMI Index
CI
09/13ADAMIS PHARMACEUTICALS : Departure of Directors of Certain Officers; Election of Directors..
PU
09/13ADAMIS PHARMACEUTICALS CORP : Change in Directors or Principal Officers (form 8-K)
AQ
09/13Adamis Pharmaceuticals Corporation Announces Resignation of Roshawn A. Blunt as Directo..
CI
09/02ADAMIS PHARMACEUTICALS : Begins Dosing Patients in Phase 2/3 Trial of Tempol to Treat COVI..
MT
09/02Adamis Pharmaceuticals Doses First Patients in Phase 2/3 Clinical Trial for Tempol in t..
GL
09/02Adamis Pharmaceuticals Corporation Doses First Patients in Phase 2/3 Clinical Trial for..
CI
08/30NORTH AMERICAN MORNING BRIEFING : Stock Futures -3-
DJ
08/24ADAMIS PHARMACEUTICALS : 8-K (Form 8-K)
PU
More news
Financials (USD)
Sales 2021 22,0 M - -
Net income 2021 -24,0 M - -
Net Debt 2021 - - -
P/E ratio 2021 -6,18x
Yield 2021 -
Capitalization 156 M 156 M -
Capi. / Sales 2021 7,11x
Capi. / Sales 2022 15,6x
Nbr of Employees 130
Free-Float 98,6%
Chart ADAMIS PHARMACEUTICALS CORPORATION
Duration : Period :
Adamis Pharmaceuticals Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ADAMIS PHARMACEUTICALS CORPORATION
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 1
Last Close Price 1,05 
Average target price
Spread / Average Target -
EPS Revisions
Managers and Directors
Dennis J. Carlo President, Chief Executive Officer & Director
David C. Benedicto Chief Financial & Accounting Officer
Richard C. Williams Chairman
Ronald B. Moss Chief Medical Officer
Karen K. Daniels Vice President-Operations
Sector and Competitors
1st jan.Capi. (M$)
ADAMIS PHARMACEUTICALS CORPORATION116.45%156
JOHNSON & JOHNSON4.75%431 543
ROCHE HOLDING AG10.05%322 644
PFIZER, INC.19.40%246 414
NOVO NORDISK A/S50.62%232 291
ELI LILLY AND COMPANY37.51%206 972